ID

34153

Beskrivning

MIBG Scintigraphy and Strain Echocardiography in the Detection of Subclinical Cardiovascular Effects One Year After (Neo)Adjuvant Breast Cancer Treatment With Docetaxel, Doxorubicin and Cyclophosphamide (TAC): a Pilot Study; ODM derived from: https://clinicaltrials.gov/show/NCT01246856

Länk

https://clinicaltrials.gov/show/NCT01246856

Nyckelord

  1. 2019-01-14 2019-01-14 -
Rättsinnehavare

see on clinicaltrials.gov

Uppladdad den

14 januari 2019

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Breast Cancer NCT01246856

Eligibility Breast Cancer NCT01246856

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
female patients with breast cancer, ≥ 18 years old at the time of breast cancer diagnosis
Beskrivning

ID.1

Datatyp

boolean

(neo)adjuvant treatment with docetaxel, doxorubicin and cyclophosphamide (tac) completed one year before inclusion
Beskrivning

ID.2

Datatyp

boolean

Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
evidence of breast cancer recurrence or metastatic disease
Beskrivning

ID.3

Datatyp

boolean

evidence of heart disease at the time of breast cancer diagnosis
Beskrivning

ID.4

Datatyp

boolean

evidence of renal failure at the time of cardiac evaluation
Beskrivning

ID.5

Datatyp

boolean

pregnant or lactating
Beskrivning

ID.6

Datatyp

boolean

participation in a research protocol with ionizing radiation within one year before inclusion.
Beskrivning

ID.7

Datatyp

boolean

evidence of diabetes mellitus or parkinson's disease
Beskrivning

ID.8

Datatyp

boolean

evidence of an mibg-accumulating tumor (pheochromocytoma, paraganglioma, chemodectoma, ganglioneuroma, neuroblastoma, carcinoid, medullary thyroid cancer, neurofibromatosis, retinoblastoma, esthesioneuroma, schwannoma, merkelcel-tumor, pancreatic islet cell tumors, small cell lung carcinoma, melanoma
Beskrivning

ID.9

Datatyp

boolean

Similar models

Eligibility Breast Cancer NCT01246856

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
female patients with breast cancer, ≥ 18 years old at the time of breast cancer diagnosis
boolean
ID.2
Item
(neo)adjuvant treatment with docetaxel, doxorubicin and cyclophosphamide (tac) completed one year before inclusion
boolean
Item Group
C0680251 (UMLS CUI)
ID.3
Item
evidence of breast cancer recurrence or metastatic disease
boolean
ID.4
Item
evidence of heart disease at the time of breast cancer diagnosis
boolean
ID.5
Item
evidence of renal failure at the time of cardiac evaluation
boolean
ID.6
Item
pregnant or lactating
boolean
ID.7
Item
participation in a research protocol with ionizing radiation within one year before inclusion.
boolean
ID.8
Item
evidence of diabetes mellitus or parkinson's disease
boolean
ID.9
Item
evidence of an mibg-accumulating tumor (pheochromocytoma, paraganglioma, chemodectoma, ganglioneuroma, neuroblastoma, carcinoid, medullary thyroid cancer, neurofibromatosis, retinoblastoma, esthesioneuroma, schwannoma, merkelcel-tumor, pancreatic islet cell tumors, small cell lung carcinoma, melanoma
boolean

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial